[Preventive and therapeutic measures in cytostatic-associated toxicity]
- PMID: 2218458
[Preventive and therapeutic measures in cytostatic-associated toxicity]
Abstract
Strategies (both prophylactic and therapeutic) to reduce side effects of chemotherapy are reviewed. In particular, issues concerning proper patient information are discussed which should help to increase patient compliance. Chemotherapy, especially regimens with a curative intent, must normally be administered under the guidance of an oncologist. However, close cooperation with the general practitioner is essential in order to ensure high quality counselling and treatment of the outpatient.
Similar articles
-
[Drug side effects in antineoplastic and immunosuppressive cytostatic therapy].Z Gesamte Inn Med. 1984 Jan 1;39(1):7-14. Z Gesamte Inn Med. 1984. PMID: 6711064 German.
-
Toxicity study of BCNU (NSC-409962) given orally.Cancer Chemother Rep. 1974 May-Jun;58(3):407-11. Cancer Chemother Rep. 1974. PMID: 4601671 Clinical Trial. No abstract available.
-
Toxicity of nonsteroidal anti-inflammatory drugs.Med Lett Drugs Ther. 1983 Feb 4;25(628):15-6. Med Lett Drugs Ther. 1983. PMID: 6823224 No abstract available.
-
Current role of chemotherapy protectors in cancer treatment.Bol Asoc Med P R. 1997 Oct-Dec;89(10-12):184-8. Bol Asoc Med P R. 1997. PMID: 9577052 Review.
-
[Terminal care. II. Easing of symptoms of cancer patients. 5. Management of adverse effects of antineoplastic agents].Nihon Naika Gakkai Zasshi. 1996 Dec 10;85(12):2032-8. Nihon Naika Gakkai Zasshi. 1996. PMID: 9036169 Review. Japanese. No abstract available.